Shockwave Medical, Inc. (SWAV)
May 31, 2024 - SWAV was delisted (reason: acquired by JNJ)
334.75
0.00 (0.00%)
Inactive · Last trade price on May 30, 2024

ShockWave Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
281.67328.42156.5989.2150.42139.05
Short-Term Investments
747.56662.13147.91111.77151.9356.3
Cash & Short-Term Investments
1,029990.55304.49200.98202.35195.35
Cash Growth
146.90%225.31%51.50%-0.68%3.59%392.77%
Receivables
124.44114.5571.3737.4411.697.38
Inventory
111.22107.5975.1142.9829.8612.07
Prepaid Expenses
10.4612.578.294.512.41.9
Total Current Assets
1,2751,225459.26285.9246.3216.7
Property, Plant & Equipment
113.6198.6380.5251.8623.9313.74
Long-Term Investments
2.361.643.515.99--
Goodwill
39.5739.57----
Other Intangible Assets
91.9692.86----
Long-Term Deferred Tax Assets
111.999.1797.57---
Other Long-Term Assets
99.445.231.941.811.51
Total Assets
1,6441,567646.09345.68272.04231.94
Accounts Payable
9.848.876.723.521.472.79
Accrued Expenses
69.7883.9150.7836.7717.4213.78
Current Portion of Long-Term Debt
---5.53.36.67
Current Portion of Leases
3.653.641.281.740.870.77
Other Current Liabilities
9.057.794.64.12.53-
Total Current Liabilities
92.33104.2163.3751.6325.5824.01
Long-Term Debt
732.81731.8624.211.6313.327.15
Long-Term Leases
40.3435.134.9328.327.498.13
Long-Term Unearned Revenue
12.2712.2712.2712.27--
Long-Term Deferred Tax Liabilities
3.613.61----
Other Long-Term Liabilities
10.6310.83----
Total Liabilities
891.99897.89134.77103.8546.3939.29
Common Stock
0.040.040.040.040.040.03
Additional Paid-In Capital
586.02557.88548.96494.81469.28370.56
Retained Earnings
165.81110.47-36.81-252.81-243.67-177.97
Comprehensive Income & Other
-0.110.29-0.87-0.20.010.04
Total Common Equity
751.76668.68511.32241.83225.65192.65
Shareholders' Equity
751.76668.68511.32241.83225.65192.65
Total Liabilities & Equity
1,6441,567646.09345.68272.04231.94
Total Debt
776.8770.6160.447.1924.9822.72
Net Cash (Debt)
252.43219.95244.09153.79177.37172.63
Net Cash Growth
-8.96%-9.89%58.71%-13.30%2.75%601.95%
Net Cash Per Share
6.595.766.444.385.367.22
Filing Date Shares Outstanding
37.5437.436.535.6534.8431.77
Total Common Shares Outstanding
37.5136.9936.2435.4434.6831.45
Working Capital
1,1831,121395.89234.27220.72192.69
Book Value Per Share
20.0418.0814.116.826.516.13
Tangible Book Value
620.23536.25511.32241.83225.65192.65
Tangible Book Value Per Share
16.5414.5014.116.826.516.13
Land
-2.27----
Buildings
-12.17----
Machinery
-21.5313.968.55.715.33
Construction In Progress
-11.029.773.547.80.55
Leasehold Improvements
-38.1733.717.745.811.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q